A giant drug company under fire over the price of EpiPens received a sales boost with the help of an education group led by the CEO’s mother, a report revealed Tuesday.
The price of the lifesaving Mylan product for severe allergic reactions jumped by over 500% since 2007 to $608 for a two-pack of the injector devices. Mylan CEO Heather Bresch will testify Wednesday at a Congressional hearing on “justified outrage” from families and schools.
